BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹14,069 Cr | ₹14,334 Cr | ₹15,359 Cr | ₹8,511 Cr | ₹3,828 Cr |
What is the latest Total Current Liabilities ratio of BIOCON ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹14,069 Cr |
| Mar2025 | ₹14,334 Cr |
| Mar2024 | ₹15,359 Cr |
| Mar2023 | ₹8,511 Cr |
| Mar2022 | ₹3,828 Cr |
How is Total Current Liabilities of BIOCON Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹14,069 Cr | -1.85 | |
| Mar2025 | ₹14,334 Cr | -6.67 | |
| Mar2024 | ₹15,359 Cr | 80.46 | |
| Mar2023 | ₹8,511 Cr | 122.33 | |
| Mar2022 | ₹3,828 Cr | - | |
Compare Total Current Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹56,795.0 Cr | -5.8% | -11.2% | -0.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -5.8% |
-11.2% |
-0.9% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses